Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-22T15:31:27.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Campylobacter coli Myocarditis: a case report

Part of: Advanced Imaging

Published online by Cambridge University Press:  06 December 2021

Sílvia A. Gomes Open the ORCID record for Sílvia A. Gomes [Opens in a new window] ,
Conceição Trigo  and
Fátima F. Pinto
Sílvia A. Gomes*
Affiliation:
Pediatric Cardiology Service, Hospital de Santa Marta, Lisbon, Portugal
Conceição Trigo
Affiliation:
Pediatric Cardiology Service, Hospital de Santa Marta, Lisbon, Portugal
Fátima F. Pinto
Affiliation:
Pediatric Cardiology Service, Hospital de Santa Marta, Lisbon, Portugal
*
Address for correspondence: Dr. Sílvia A. Gomes, Pediatric Cardiology Service, Hospital de Santa Marta, Rua de Santa Marta 50, 1169-024, Lisbon, Portugal. Tel: +351 213594332. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

We report the case of a 14-year-old male presented with raised myocardial injury biomarkers, on the workout, Campylobacter coli was identified on stool culture, treated with antibiotics with total resolution. Cardiac magnetic resonance showed interventricular septum and lateral wall hypokinesia and subepicardial delayed enhancement, with preserved ventricular systolic function. To our knowledge, this is the first report linking Campylobacter coli to myopericarditis in children.

Keywords

MyocarditisCampylobacter colichildren
Type
Brief Report
Information
Cardiology in the Young , Volume 32 , Issue 7 , July 2022 , pp. 1172 - 1174
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Caforio, ALP, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J, 2013; 34: 2636–2648.CrossRefGoogle Scholar
Obafemi, MT, Douglas, H. Campylobacter jejuni myocarditis: a journey from the gut to the heart. SAGE Open Med Case Rep, 2017; 5: 1–3.Google ScholarPubMed
Imanaka-Yoshida, K. Inflammation in myocardial disease: from myocarditis to dilated cardiomyopathy. Pathol Int, 2020; 70: 1–11.CrossRefGoogle ScholarPubMed
Moffatt, CRM, Moloi, SB, Kennedy, K. First case report of myopericarditis linked to Campylobacter coli enterocolitis. BMC Infect Dis, 2017; 17: 8.10.1186/s12879-016-2115-9CrossRefGoogle ScholarPubMed
Schiaffino, F, Colston, JM, Paredes-Olortegui, M, et al. Antibiotic resistance of campylobacter species in a pediatric cohort study. Antimicrob Agents Chemother, 2019; 63: e01911–e01918.CrossRefGoogle Scholar
Blauwet, LA, Cooper, LT. Myocarditis. Prog Cardiovasc Dis, 2010; 52: 274–288.10.1016/j.pcad.2009.11.006CrossRefGoogle ScholarPubMed
Wanby, P, Olsen, B. Myocarditis in a Patient with Salmonella and Campylobacter enteritis. Scand J Infect Dis. 2001; 33: 860–862.Google Scholar
Hessulf, F, Ljungberg, J, Johansson, PA, Lindgren, M, Engdahl, J. Campylobacter jejuni-associated perimyocarditis: two case reports and review of the literature. BMC Infect Dis, 2016; 16: 289.CrossRefGoogle ScholarPubMed
Uzoigwe, C. Campylobacter infections of the pericardium and myocardium. Clin Microbiol Infect. 2005; 11: 253–255.CrossRefGoogle ScholarPubMed
Wassenaar, TM. Toxin Production by Campylobacter spp . Clin Microbiol Rev, July 1997: 466–476.10.1128/CMR.10.3.466CrossRefGoogle ScholarPubMed